ITC-PAC R&D "Establishment of Clinically Feasible Direct Reprogramming Procedures Leading to a Cell-based Therapy for Bone Injury"

Award Notice Posted

Solicitation number
FA5209-17-T-0038
Agency
Awarded
to Nippon Medical & Chemical Instruments Co., LTD.
Set-aside
No set-aside

Opportunity facts

Contract number
FA520917P0038 Federal contract award
NAICS code
541720 Research and Development in the Social Sciences and Humanities
PSC
Not on record
Place of performance
3-9, Tamatsukurimotomachi, Tennoji-ku, Hakko Bldg. 7F, Osaka Osaka, 543-0014 Japan

Notice details come from SAM.gov. Updated .

Notice text

Subject service is being acquired as ITC-PAC Research Project for "Establishment of Clinically Feasible Direct Reprogramming Procedures Leading to a Cell-based Therapy for Bone Injury". We will award Nippon Medical & Chemical Instruments Co., Ltd. as sole source contractor. Nature of this contract is a grant rather than a normal contract. Initially, we tried to make a grant IAW 10.U.S.C. 2358 and 31 U.S.C. 6304. However, we found out that our contract writing system at overseas did not allow making a grant.

Files

File Type Posted
Supplement_SSJ_FBO.pdf PDF
FA520917T0038_FBO.pdf PDF
SOW_NMCI_FBO.pdf PDF
SSJ_FBO.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors